Bio-better avoids preliminary injunction in Germany
The first preliminary injunction decision in Germany relating to a ‘bio-better’-type drug has been made in Amgen v Teva in the Düsseldorf District Court. The injunction was rejected and an appeal is pending.
The product of Amgen, Lipegfilgastrim, the owner of the patent for which enforcement was sought, was not itself covered by the patent…
If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
Tribunals will have the power to order that an employer who is unsuccessful at tribunal pay a financial penalty on top of any compensation due to the successful claimant.
With technological developments and the increase of CCTV in public places, the role of regulation and guidance will become increasingly important.
Analysis from The Lawyer
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world
Financial disputes are starting to dominate the English courts as the long-awaited fallout from the downturn finally comes to town